EW Stock-Based Compensation
Edwards Lifesciences · Stock-Based Compensation
EW Stock-Based Compensation
Latest reported$168.00Mperiod ending
EW TTM Stock-Based Comp ($0.00 → $168.00M)
TTM stock-based compensation
High-resolution chart · PNG
EW stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 168,000,000 | |
| 163,300,000 | |
| 158,100,000 | |
| 169,700,000 | |
| 170,600,000 | |
| 177,000,000 | |
| 181,400,000 | |
| 161,100,000 | |
| 151,600,000 | |
| 145,100,000 | |
| 139,400,000 | |
| 136,800,000 | |
| 134,500,000 | |
| 133,300,000 | |
| 126,800,000 | |
| 123,100,000 | |
| 119,400,000 | |
| 113,500,000 | |
| 109,300,000 | |
| 106,000,000 | |
| 102,400,000 | |
| 96,900,000 | |
| 92,600,000 | |
| 90,100,000 | |
| 86,900,000 | |
| 84,400,000 | |
| 81,300,000 | |
| 78,900,000 | |
| 76,500,000 | |
| 73,400,000 | |
| 71,000,000 | |
| 70,300,000 | |
| 68,700,000 | |
| 64,800,000 | |
| 61,600,000 | |
| 60,200,000 | |
| 58,800,000 | |
| 57,800,000 | |
| 56,900,000 | |
| 55,900,000 | |
| 54,100,000 | |
| 50,600,000 | |
| 49,900,000 | |
| 49,200,000 | |
| 48,800,000 | |
| 49,900,000 | |
| 48,300,000 | |
| 47,600,000 | |
| 47,300,000 | |
| 48,200,000 | |
| 47,400,000 | |
| 46,700,000 | |
| 45,700,000 | |
| 44,100,000 | |
| 42,100,000 | |
| 40,300,000 | |
| 39,900,000 | |
| 36,500,000 | |
| 35,000,000 | |
| 32,900,000 | |
| 31,000,000 | |
| 29,500,000 | |
| 29,300,000 | |
| 30,200,000 | |
| 29,500,000 | |
| 28,900,000 | |
| 28,300,000 | |
| 49,200,000 | |
| 41,300,000 | |
| 41,800,000 | |
| 41,500,000 | |
| 40,500,000 | |
| 40,500,000 | |
| 34,300,000 | |
| 34,600,000 | |
| 33,500,000 | |
| 33,500,000 | |
| 33,500,000 | |
| 32,400,000 | |
| 5,800,000 | |
| 5,800,000 | |
| 5,800,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |